Skip to content

Security Incident – July 27th

ASET has been made aware that an employee email account was compromised, potentially resulting in the distribution of malicious emails. Steps were swiftly taken to secure the compromised account and are working to identify and notify any individuals who may have been directly impacted.

If you received an email from [email protected] on July 27th between 11:45am and 12:15pm CDT, please DO NOT open it, click on any links, download any attachments, or respond. Instead, please delete the message immediately.

If you interacted with a suspicious email, we strongly recommend the following:

  • Change your email password immediately.
  • Scan your device for malware.
  • If you are using an employer-owned device, please notify your IT department of a potential compromise.

Your security is a top priority for ASET. We appreciate your cooperation in helping us protect our community.

Enhance Your Professional Journey with ASET


ASET offers leadership, advocacy, and resources to support neurodiagnostic technologists.

Your membership helps us promote and elevate our profession while supporting technologists worldwide. Thank you!

Meet an Author!


Victoria Celis discusses her paper on pseudocholinesterase deficiency with Editor-in-Chief of The Neurodiagnostic Journal, Dr. Mark Stecker. She highlights a case where a patient showed no response to the train of four (TOF) after succinylcholine administration. Despite troubleshooting and using a handheld stimulator, no response was observed. The patient was later confirmed to have pseudocholinesterase deficiency. Celis emphasizes the importance of early TOF monitoring and collaboration with the surgical team to manage such cases effectively.